HCA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

19.67B

+7.58%

7.469

+20.09%

19.18B

+4.71%

7.202

+11.65%

19.43B

+4.43%

7.527

+10.04%

Estimates Revision

The market is revising Upward the revenue expectations for HCA Healthcare, Inc. (HCA) for FY2025, with the revenue forecasts being adjusted by 0.94% over the past three months. During the same period, the stock price has changed by 17.52%.

Revenue Estimates for FY2025

Revise Upward

+0.94%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+4.88%

In Past 3 Month

Stock Price

Go Up

+17.52%

In Past 3 Month

19 Analyst Rating

Wall Street analysts forecast HCA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCA is 481.33 USD with a low forecast of 417.00 USD and a high forecast of 525.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

13 Buy

6 Hold

0 Sell

Moderate Buy

Current: 469.790

Low

417.00

Averages

481.33

High

525.00

Current: 469.790

Low

417.00

Averages

481.33

High

525.00

Morgan Stanley

Craig Hettenbach

Equal Weight -> Underweight

downgrade

$425

2025-12-15

New

Reason

Morgan Stanley

Craig Hettenbach

Price Target

$425

2025-12-15

New

downgrade

Equal Weight -> Underweight

Reason

Morgan Stanley analyst Craig Hettenbach downgraded HCA Healthcare to Underweight from Equal Weight with an unchanged price target of $425. Following the stock's significant outperformance that has HCA trading at a new peak valuation multiple, "there's little room for any setbacks," the analyst tells investors in a research note. The firm thinks upside is already priced in following strong outperformance in the stock.

Wells Fargo

Equal Weight

maintain

$412 -> $431

2025-11-13

Reason

Wells Fargo

Price Target

$412 -> $431

2025-11-13

maintain

Equal Weight

Reason

Wells Fargo raised the firm's price target on HCA Healthcare to $431 from $412 and keeps an Equal Weight rating on the shares following quarterly results. Overall, modestly higher EBITDA estimates and rolling fully to 2027 estimates offsets a material increase in the odds of enhanced exchange subsidies expiring in the firm's price target framework, Wells says.

Jefferies

Buy

maintain

$485 -> $525

2025-10-28

Reason

Jefferies

Price Target

$485 -> $525

2025-10-28

maintain

Buy

Reason

Jefferies raised the firm's price target on HCA Healthcare to $525 from $485 and keeps a Buy rating on the shares after "a good Q3, with a solid EBITDA beat." The magnitude of the Q3 beat highlighted how significant the upside could be from other upcoming state-directed payments approvals and made investors overlook the impasse in Congress over health insurance exchange subsidies, the analyst contends.

Oppenheimer

Outperform

maintain

$400 -> $500

2025-10-27

Reason

Oppenheimer

Price Target

$400 -> $500

2025-10-27

maintain

Outperform

Reason

Oppenheimer raised the firm's price target on HCA Healthcare to $500 from $400 and keeps an Outperform rating on the shares. The firm notes the company reported strong Q3 results, driven by revenue-per-adjusted admission, largely due to outsized tailwinds from state supplemental payments, along with other factors, which implies high single-digit growth for Q4 2025 after adjusting for the moving parts from supp. payments and the hurricanes from last year.

Cantor Fitzgerald

Sarah James

Overweight

maintain

$444 -> $525

2025-10-27

Reason

Cantor Fitzgerald

Sarah James

Price Target

$444 -> $525

2025-10-27

maintain

Overweight

Reason

Cantor Fitzgerald analyst Sarah James raised the firm's price target on HCA Healthcare to $525 from $444 and keeps an Overweight rating on the shares. HCA Heatlhcare's operational excellence persists as it paves an achievable path to 2025 guidance and an optimistic 2026 outlook, the analyst tells investors in a research note. Preliminary 2026 commentary suggests fundamentals are well-intact, the firm adds.

Goldman Sachs

Scott Fidel

Buy

maintain

$470 -> $520

2025-10-27

Reason

Goldman Sachs

Scott Fidel

Price Target

$470 -> $520

2025-10-27

maintain

Buy

Reason

Goldman Sachs analyst Scott Fidel raised the firm's price target on HCA Healthcare to $520 from $470 and keeps a Buy rating on the shares.

Valuation Metrics

The current forward P/E ratio for HCA Healthcare Inc (HCA.N) is 16.17, compared to its 5-year average forward P/E of 13.77. For a more detailed relative valuation and DCF analysis to assess HCA Healthcare Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

13.77

Current PE

16.17

Overvalued PE

15.41

Undervalued PE

12.14

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

8.95

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

9.63

Undervalued EV/EBITDA

8.27

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

1.16

Current PS

0.00

Overvalued PS

1.29

Undervalued PS

1.02

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

HCA News & Events

Events Timeline

No data

News

6.0

12-15Yahoo Finance

Morgan Stanley Lowers HCA Healthcare Rating to Underweight from Equalweight, Price Target Set at $425

4.5

12-11NASDAQ.COM

Majority of Stocks Bounce Back After Oracle's Sell-Off

8.0

12-11NASDAQ.COM

Upcoming Ex-Dividend Dates for DT Midstream, HCA Healthcare, and Thermo Fisher Scientific

People Also Watch

Frequently Asked Questions

What is HCA Healthcare Inc (HCA) stock price today?

The current price of HCA is 469.79 USD — it has decreased -1.51 % in the last trading day.

What is HCA Healthcare Inc (HCA)'s business?

HCA Healthcare, Inc. is a health care services company. It owns, manages or operates hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals and 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

What is the price predicton of HCA Stock?

What is HCA Healthcare Inc (HCA)'s revenue for the last quarter?

HCA Healthcare Inc revenue for the last quarter amounts to 19.16B USD, increased 9.57 % YoY.

What is HCA Healthcare Inc (HCA)'s earnings per share (EPS) for the last quarter?

HCA Healthcare Inc. EPS for the last quarter amounts to 6.96 USD, increased 42.33 % YoY.

What changes have occurred in the market's expectations for HCA Healthcare Inc (HCA)'s fundamentals?

How many employees does HCA Healthcare Inc (HCA). have?

HCA Healthcare Inc (HCA) has 226000 emplpoyees as of December 16 2025.

What is HCA Healthcare Inc (HCA) market cap?

Today HCA has the market capitalization of 108.84B USD.